The group's principle activity is to provide clinical pharmacology, regulatory affairs, pharmacokinetics, pharmacometrics, biopharmaceutics, and bioanalytical, ICON development solutions. The group's products include NONMEM, PDx-Pop(R), PDx-IVIVC(R), and PDx-MC-PEM(R). The group operates from United States.